The decreased plasma level may be caused by proteolytic degradation of IGF-1 binding protein-3 resulting in an increased clearance of IGF-1, as previously shown in a model of juvenile arthritis induced by IL-6 overexpression37. The gene discussed is IGF1; the disease is juvenile idiopathic arthritis.